Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia
Xiaoe Lang, Qinqin Liu, Han-liu Fang, et al.
Psychopharmacology (2021) Vol. 238, Iss. 12, pp. 3643-3652
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu‐Hua Wu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7092-7092
Open Access | Times Cited: 24
Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients
Kuan Zeng, Shuo Wang, Lin Zhang, et al.
Annals of General Psychiatry (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Managing co-occurring physical disorders in mental health care
Delia Cimpean Hendrick, Robert E. Drake
Oxford University Press eBooks (2025), pp. 233-242
Closed Access
Prevalence of metabolic syndrome and its associated factors in first‐treatment drug‐naïve schizophrenia patients: A large‐scale cross‐sectional study
Suoya Hu, Xuebing Liu, Yanting Zhang, et al.
Early Intervention in Psychiatry (2024)
Closed Access | Times Cited: 3
Shared genetic components between metabolic syndrome and schizophrenia: Genetic correlation using multipopulation data sets
Rei Aoki, Takeo Saito, Kohei Ninomiya, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 76, Iss. 8, pp. 361-366
Open Access | Times Cited: 15
Variability of glucose, insulin, and lipid disturbances in first-episode psychosis: a meta-analysis
Toby Pillinger, Robert A. McCutcheon, Oliver Howes
Psychological Medicine (2022) Vol. 53, Iss. 7, pp. 3150-3156
Open Access | Times Cited: 14
The role of metformin in treatment of weight gain associated with atypical antipsychotic treatment in children and adolescents: A systematic review and meta-analysis of randomized controlled trials
Zeeshan Mansuri, Ramkrishna Makani, Chintan Trivedi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 10
Global Prevalence of Metabolic Syndrome in Schizophrenia Patients: A Systematic Review and Meta-Analysis
Nader Salari, Nima Maghami, Theo Ammari, et al.
Journal of Prevention (2024) Vol. 45, Iss. 6, pp. 973-986
Closed Access | Times Cited: 1
Cardiovascular disease risk in people with severe mental disorders: an update and call for action
Linn Rødevand, Martin Tesli, Ole A. Andreassen
Current Opinion in Psychiatry (2022) Vol. 35, Iss. 4, pp. 277-284
Open Access | Times Cited: 6
Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome
Anastasiia S. Boiko, Irina A. Mednova, Elena G. Kornetova, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 5
Exploring the Association between Schizophrenia and Cardiovascular Diseases: Insights into the Role of Sigma 1 Receptor
J Rafcikova, M. Nováková, Tibor Stračina
Physiological Research (2023), pp. S113-S126
Open Access | Times Cited: 2
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia
Tan-yu Huang, Li-chang Chen, Xiaoping Li, et al.
Schizophrenia Research (2023) Vol. 264, pp. 113-121
Closed Access | Times Cited: 2
miR-137 regulates PTP61F, affecting insulin signaling, metabolic homeostasis, and starvation resistance in Drosophila
Hana Saedi, Girma Waro, Lea Giacchetta, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 5
Open Access
Gender Differences in the Prevalence and Clinical Correlates of Metabolic Syndrome in First-Episode and Drug-Naïve Patients With Major Depressive Disorder
Jianjun Zhang, Jingxia Wang, Xiaoqian Wang, et al.
Psychosomatic Medicine (2024) Vol. 86, Iss. 3, pp. 202-209
Closed Access
Influencing factors of different metabolic status in hospitalized patients with schizophrenia
M Ding, Shaotong Zhang, Zaochen Zhu, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Prevalence and risk factors of hyperuricemia among patients with schizophrenia in a public psychiatric hospital in China
Haijing Li, Wenying Yi, Yingjun Zheng, et al.
Research Square (Research Square) (2024)
Closed Access
Evaluation of Clinical Correlation between Insulin Resistance and Antipsychotic Drug Therapy in Patients with Schizophrenia
Fang Wang, Faya Wang, Xiaoqing Tao, et al.
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 4, pp. 412-419
Open Access
Gender differences in clinical characteristics and influencing factors of suicide attempts in first-episode and drug-naïve major depressive disorder patients with comorbid metabolic syndrome
Ping Sun, Yingying Huang, Hui Yu, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access
Clinical patterns of metabolic syndrome in young, clinically stable, olanzapine-exposed patients with schizophrenia
Jun Ma, Lin Zhang, Zhengyuan Huang, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access
Relationship between efficacy and common metabolic parameters in first-treatment drug-naïve patients with early non-response schizophrenia: a retrospective study
Junhong Zhu, Jiajia Wu, Xuebing Liu, et al.
Annals of General Psychiatry (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Somatotype and morphological characteristics of metabolic syndrome in patients with schizophrenia and persons without mental disorders
Elena G. Kornetova, A. A. Goncharova, Irina A. Mednova, et al.
Bulletin of Siberian Medicine (2023) Vol. 22, Iss. 1, pp. 57-64
Open Access | Times Cited: 1
Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort
Nathalia Garrido-Torres, Miguel Ruiz‐Veguilla, Júlia Olivé Mas, et al.
Spanish Journal of Psychiatry and Mental Health (2022) Vol. 16, Iss. 3, pp. 175-183
Closed Access | Times Cited: 2
Factors influencing prolactin levels in chronic long-term hospitalized schizophrenic patients with co-morbid type 2 diabetes mellitus
Junhong Zhu, Huijuan Wang, Shaoyun Huang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 2
Influencing factors of obesity in community patients with deficit schizophrenia: a cross-sectional study
Yong Na, Jiyang Pan, Xuehua Li, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Is platelet activation a link between metabolic syndrome and cognitive impairment in patients with schizophrenia?
Olaoluwa Okusaga, K. Vinod Vijayan, Rolando E. Rumbaut
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1 - Next Page

Scroll to top